1-3 of 3
Tetsuya Yoshino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evi-1 Interacts with Histone Methyltransferases for Transcription Repression and Bone Marrow Transformation.

Susumu Goyama, Eriko Nitta, Munetake Shimabe, Tetsuya Yoshino, Shinichi Kako, Motoshi Ichikawa, Yoichi Imai, Tsuyoshi Takahashi, Akira Hangaishi, Mineo Kurokawa, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2257.
https://doi.org/10.1182/blood.V112.11.2257.2257
Published: 2008
Journal Articles

Single Oral Administration of KRN383, a Novel Flt3 Inhibitor, Induces Eradication of the Xenograft Tumor Harboring Flt3 Mutation in Mice.

Uichi Nishiyama, Masako Ozai, Rieko Yoshioka, Tetsuya Yoshino, Yuko Ogasawara, Miyuki Kitahori, Eiji Yoshioka, Kazuo Kubo, Yukiko Komeno, MD, Mineo Kurokawa, MD, PhD, Seishi Ogawa, MD, PhD, Shigeru Chiba, MD, PhD, Tatsushi Osawa, PhD, Tomoaki Kuwaki, Hisamaru Hirai, MD, PhD, Atsushi Miwa, PhD
Journal: Blood
Blood (2004) 104 (11): 2545.
https://doi.org/10.1182/blood.V104.11.2545.2545
Published: 2004
Journal Articles

Ki23819 (KRN383•HCl) Inhibits Kinase Activity of Wild Type and Mutant FLT3 Receptor Tyrosine Kinase In Vitro .

Yukiko Komeno, Mineo Kurokawa, Yoichi Imai, Masataka Takeshita, Tomoko Matsumura, Kazuo Kubo, Tetsuya Yoshino, Uichi Nishiyama, Tomoaki Kuwaki, Kinya Kubo, Tatsushi Osawa, Seishi Ogawa, Shigeru Chiba, Atsushi Miwa, Hisamaru Hirai
Journal: Blood
Blood (2004) 104 (11): 1168.
https://doi.org/10.1182/blood.V104.11.1168.1168
Published: 2004